देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
orlistat, Quantity: 120 mg
Arrotex Pharmaceuticals Pty Ltd
Capsule, hard
Excipient Ingredients: Gelatin; sodium starch glycollate type A; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; sodium lauryl sulfate; indigo carmine aluminium lake
Oral
9, 42, 21, 84
(S3) Pharmacist Only Medicine
Orlistat GPPL is indicated for the treatment of obese patients with a body mass index (BMI) ? 30, and overweight patients with a BMI ? 27 in the presence of other risk factors, in conjunction with a mildly hypocaloric diet
Visual Identification: Hard gelatin blue capsules containing loose white powder or slightly compacted agglomerates of powder.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2018-10-02